Pharma & Healthcare
Global Mesalazine Enteric Coated Tablets Market Research Report 2026
- Mar 17, 26
- ID: 742237
- Pages: 110
- Figures: 115
- Views: 2
This report delivers a comprehensive overview of the global Mesalazine Enteric Coated Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mesalazine Enteric Coated Tablets. The Mesalazine Enteric Coated Tablets market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Mesalazine Enteric Coated Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mesalazine Enteric Coated Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Dr. Falk Pharma GmbH
Astellas Pharma Inc.
AbbVie Inc.
DSM Pharmaceuticals
Sun Pharmaceutical Industries Ltd.
Fosun Pharma
Huahai Pharmaceuticals
UCB Pharma
CR Sanjiu
Segment by Type
0.25g
0.5g
1g
by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Mesalazine Enteric Coated Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Mesalazine Enteric Coated Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Mesalazine Enteric Coated Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mesalazine Enteric Coated Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Dr. Falk Pharma GmbH
Astellas Pharma Inc.
AbbVie Inc.
DSM Pharmaceuticals
Sun Pharmaceutical Industries Ltd.
Fosun Pharma
Huahai Pharmaceuticals
UCB Pharma
CR Sanjiu
Segment by Type
0.25g
0.5g
1g
by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Mesalazine Enteric Coated Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Mesalazine Enteric Coated Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Mesalazine Enteric Coated Tablets Market Overview
1.1 Product Definition
1.2 Mesalazine Enteric Coated Tablets by Type
1.2.1 Global Mesalazine Enteric Coated Tablets Market Value by Type: 2025 vs 2032
1.2.2 0.25g
1.2.3 0.5g
1.2.4 1g
1.3 Mesalazine Enteric Coated Tablets by Application
1.3.1 Global Mesalazine Enteric Coated Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Mesalazine Enteric Coated Tablets Market Size Estimates and Forecasts
1.4.1 Global Mesalazine Enteric Coated Tablets Revenue 2021–2032
1.4.2 Global Mesalazine Enteric Coated Tablets Sales 2021–2032
1.4.3 Global Mesalazine Enteric Coated Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Mesalazine Enteric Coated Tablets Market Competition by Manufacturers
2.1 Global Mesalazine Enteric Coated Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mesalazine Enteric Coated Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mesalazine Enteric Coated Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Date of Entry into the Industry
2.8 Global Mesalazine Enteric Coated Tablets Market Competitive Situation and Trends
2.8.1 Global Mesalazine Enteric Coated Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mesalazine Enteric Coated Tablets Players Market Share by Revenue
2.8.3 Global Mesalazine Enteric Coated Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mesalazine Enteric Coated Tablets Market Scenario by Region
3.1 Global Mesalazine Enteric Coated Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mesalazine Enteric Coated Tablets Sales by Region: 2021–2032
3.2.1 Global Mesalazine Enteric Coated Tablets Sales by Region: 2021–2026
3.2.2 Global Mesalazine Enteric Coated Tablets Sales by Region: 2027–2032
3.3 Global Mesalazine Enteric Coated Tablets Revenue by Region: 2021–2032
3.3.1 Global Mesalazine Enteric Coated Tablets Revenue by Region: 2021–2026
3.3.2 Global Mesalazine Enteric Coated Tablets Revenue by Region: 2027–2032
3.4 North America Mesalazine Enteric Coated Tablets Market Facts & Figures by Country
3.4.1 North America Mesalazine Enteric Coated Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mesalazine Enteric Coated Tablets Sales by Country (2021–2032)
3.4.3 North America Mesalazine Enteric Coated Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mesalazine Enteric Coated Tablets Market Facts & Figures by Country
3.5.1 Europe Mesalazine Enteric Coated Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mesalazine Enteric Coated Tablets Sales by Country (2021–2032)
3.5.3 Europe Mesalazine Enteric Coated Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mesalazine Enteric Coated Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Mesalazine Enteric Coated Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mesalazine Enteric Coated Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Mesalazine Enteric Coated Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mesalazine Enteric Coated Tablets Market Facts & Figures by Country
3.7.1 Latin America Mesalazine Enteric Coated Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mesalazine Enteric Coated Tablets Sales by Country (2021–2032)
3.7.3 Latin America Mesalazine Enteric Coated Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mesalazine Enteric Coated Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Mesalazine Enteric Coated Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mesalazine Enteric Coated Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mesalazine Enteric Coated Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mesalazine Enteric Coated Tablets Sales by Type (2021–2032)
4.1.1 Global Mesalazine Enteric Coated Tablets Sales by Type (2021–2026)
4.1.2 Global Mesalazine Enteric Coated Tablets Sales by Type (2027–2032)
4.1.3 Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021–2032)
4.2 Global Mesalazine Enteric Coated Tablets Revenue by Type (2021–2032)
4.2.1 Global Mesalazine Enteric Coated Tablets Revenue by Type (2021–2026)
4.2.2 Global Mesalazine Enteric Coated Tablets Revenue by Type (2027–2032)
4.2.3 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Mesalazine Enteric Coated Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Mesalazine Enteric Coated Tablets Sales by Application (2021–2032)
5.1.1 Global Mesalazine Enteric Coated Tablets Sales by Application (2021–2026)
5.1.2 Global Mesalazine Enteric Coated Tablets Sales by Application (2027–2032)
5.1.3 Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021–2032)
5.2 Global Mesalazine Enteric Coated Tablets Revenue by Application (2021–2032)
5.2.1 Global Mesalazine Enteric Coated Tablets Revenue by Application (2021–2026)
5.2.2 Global Mesalazine Enteric Coated Tablets Revenue by Application (2027–2032)
5.2.3 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Mesalazine Enteric Coated Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Dr. Falk Pharma GmbH
6.1.1 Dr. Falk Pharma GmbH Company Information
6.1.2 Dr. Falk Pharma GmbH Description and Business Overview
6.1.3 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product Portfolio
6.1.5 Dr. Falk Pharma GmbH Recent Developments/Updates
6.2 Astellas Pharma Inc.
6.2.1 Astellas Pharma Inc. Company Information
6.2.2 Astellas Pharma Inc. Description and Business Overview
6.2.3 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product Portfolio
6.2.5 Astellas Pharma Inc. Recent Developments/Updates
6.3 AbbVie Inc.
6.3.1 AbbVie Inc. Company Information
6.3.2 AbbVie Inc. Description and Business Overview
6.3.3 AbbVie Inc. Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AbbVie Inc. Mesalazine Enteric Coated Tablets Product Portfolio
6.3.5 AbbVie Inc. Recent Developments/Updates
6.4 DSM Pharmaceuticals
6.4.1 DSM Pharmaceuticals Company Information
6.4.2 DSM Pharmaceuticals Description and Business Overview
6.4.3 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio
6.4.5 DSM Pharmaceuticals Recent Developments/Updates
6.5 Sun Pharmaceutical Industries Ltd.
6.5.1 Sun Pharmaceutical Industries Ltd. Company Information
6.5.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product Portfolio
6.5.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
6.6 Fosun Pharma
6.6.1 Fosun Pharma Company Information
6.6.2 Fosun Pharma Description and Business Overview
6.6.3 Fosun Pharma Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Fosun Pharma Mesalazine Enteric Coated Tablets Product Portfolio
6.6.5 Fosun Pharma Recent Developments/Updates
6.7 Huahai Pharmaceuticals
6.7.1 Huahai Pharmaceuticals Company Information
6.7.2 Huahai Pharmaceuticals Description and Business Overview
6.7.3 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio
6.7.5 Huahai Pharmaceuticals Recent Developments/Updates
6.8 UCB Pharma
6.8.1 UCB Pharma Company Information
6.8.2 UCB Pharma Description and Business Overview
6.8.3 UCB Pharma Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 UCB Pharma Mesalazine Enteric Coated Tablets Product Portfolio
6.8.5 UCB Pharma Recent Developments/Updates
6.9 CR Sanjiu
6.9.1 CR Sanjiu Company Information
6.9.2 CR Sanjiu Description and Business Overview
6.9.3 CR Sanjiu Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CR Sanjiu Mesalazine Enteric Coated Tablets Product Portfolio
6.9.5 CR Sanjiu Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mesalazine Enteric Coated Tablets Industry Chain Analysis
7.2 Mesalazine Enteric Coated Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mesalazine Enteric Coated Tablets Production Mode & Process Analysis
7.4 Mesalazine Enteric Coated Tablets Sales and Marketing
7.4.1 Mesalazine Enteric Coated Tablets Sales Channels
7.4.2 Mesalazine Enteric Coated Tablets Distributors
7.5 Mesalazine Enteric Coated Tablets Customer Analysis
8 Mesalazine Enteric Coated Tablets Market Dynamics
8.1 Mesalazine Enteric Coated Tablets Industry Trends
8.2 Mesalazine Enteric Coated Tablets Market Drivers
8.3 Mesalazine Enteric Coated Tablets Market Challenges
8.4 Mesalazine Enteric Coated Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Mesalazine Enteric Coated Tablets by Type
1.2.1 Global Mesalazine Enteric Coated Tablets Market Value by Type: 2025 vs 2032
1.2.2 0.25g
1.2.3 0.5g
1.2.4 1g
1.3 Mesalazine Enteric Coated Tablets by Application
1.3.1 Global Mesalazine Enteric Coated Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Mesalazine Enteric Coated Tablets Market Size Estimates and Forecasts
1.4.1 Global Mesalazine Enteric Coated Tablets Revenue 2021–2032
1.4.2 Global Mesalazine Enteric Coated Tablets Sales 2021–2032
1.4.3 Global Mesalazine Enteric Coated Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Mesalazine Enteric Coated Tablets Market Competition by Manufacturers
2.1 Global Mesalazine Enteric Coated Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mesalazine Enteric Coated Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mesalazine Enteric Coated Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Date of Entry into the Industry
2.8 Global Mesalazine Enteric Coated Tablets Market Competitive Situation and Trends
2.8.1 Global Mesalazine Enteric Coated Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mesalazine Enteric Coated Tablets Players Market Share by Revenue
2.8.3 Global Mesalazine Enteric Coated Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mesalazine Enteric Coated Tablets Market Scenario by Region
3.1 Global Mesalazine Enteric Coated Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mesalazine Enteric Coated Tablets Sales by Region: 2021–2032
3.2.1 Global Mesalazine Enteric Coated Tablets Sales by Region: 2021–2026
3.2.2 Global Mesalazine Enteric Coated Tablets Sales by Region: 2027–2032
3.3 Global Mesalazine Enteric Coated Tablets Revenue by Region: 2021–2032
3.3.1 Global Mesalazine Enteric Coated Tablets Revenue by Region: 2021–2026
3.3.2 Global Mesalazine Enteric Coated Tablets Revenue by Region: 2027–2032
3.4 North America Mesalazine Enteric Coated Tablets Market Facts & Figures by Country
3.4.1 North America Mesalazine Enteric Coated Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mesalazine Enteric Coated Tablets Sales by Country (2021–2032)
3.4.3 North America Mesalazine Enteric Coated Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mesalazine Enteric Coated Tablets Market Facts & Figures by Country
3.5.1 Europe Mesalazine Enteric Coated Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mesalazine Enteric Coated Tablets Sales by Country (2021–2032)
3.5.3 Europe Mesalazine Enteric Coated Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mesalazine Enteric Coated Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Mesalazine Enteric Coated Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mesalazine Enteric Coated Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Mesalazine Enteric Coated Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mesalazine Enteric Coated Tablets Market Facts & Figures by Country
3.7.1 Latin America Mesalazine Enteric Coated Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mesalazine Enteric Coated Tablets Sales by Country (2021–2032)
3.7.3 Latin America Mesalazine Enteric Coated Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mesalazine Enteric Coated Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Mesalazine Enteric Coated Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mesalazine Enteric Coated Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mesalazine Enteric Coated Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mesalazine Enteric Coated Tablets Sales by Type (2021–2032)
4.1.1 Global Mesalazine Enteric Coated Tablets Sales by Type (2021–2026)
4.1.2 Global Mesalazine Enteric Coated Tablets Sales by Type (2027–2032)
4.1.3 Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021–2032)
4.2 Global Mesalazine Enteric Coated Tablets Revenue by Type (2021–2032)
4.2.1 Global Mesalazine Enteric Coated Tablets Revenue by Type (2021–2026)
4.2.2 Global Mesalazine Enteric Coated Tablets Revenue by Type (2027–2032)
4.2.3 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Mesalazine Enteric Coated Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Mesalazine Enteric Coated Tablets Sales by Application (2021–2032)
5.1.1 Global Mesalazine Enteric Coated Tablets Sales by Application (2021–2026)
5.1.2 Global Mesalazine Enteric Coated Tablets Sales by Application (2027–2032)
5.1.3 Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021–2032)
5.2 Global Mesalazine Enteric Coated Tablets Revenue by Application (2021–2032)
5.2.1 Global Mesalazine Enteric Coated Tablets Revenue by Application (2021–2026)
5.2.2 Global Mesalazine Enteric Coated Tablets Revenue by Application (2027–2032)
5.2.3 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Mesalazine Enteric Coated Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Dr. Falk Pharma GmbH
6.1.1 Dr. Falk Pharma GmbH Company Information
6.1.2 Dr. Falk Pharma GmbH Description and Business Overview
6.1.3 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product Portfolio
6.1.5 Dr. Falk Pharma GmbH Recent Developments/Updates
6.2 Astellas Pharma Inc.
6.2.1 Astellas Pharma Inc. Company Information
6.2.2 Astellas Pharma Inc. Description and Business Overview
6.2.3 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product Portfolio
6.2.5 Astellas Pharma Inc. Recent Developments/Updates
6.3 AbbVie Inc.
6.3.1 AbbVie Inc. Company Information
6.3.2 AbbVie Inc. Description and Business Overview
6.3.3 AbbVie Inc. Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AbbVie Inc. Mesalazine Enteric Coated Tablets Product Portfolio
6.3.5 AbbVie Inc. Recent Developments/Updates
6.4 DSM Pharmaceuticals
6.4.1 DSM Pharmaceuticals Company Information
6.4.2 DSM Pharmaceuticals Description and Business Overview
6.4.3 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio
6.4.5 DSM Pharmaceuticals Recent Developments/Updates
6.5 Sun Pharmaceutical Industries Ltd.
6.5.1 Sun Pharmaceutical Industries Ltd. Company Information
6.5.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product Portfolio
6.5.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
6.6 Fosun Pharma
6.6.1 Fosun Pharma Company Information
6.6.2 Fosun Pharma Description and Business Overview
6.6.3 Fosun Pharma Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Fosun Pharma Mesalazine Enteric Coated Tablets Product Portfolio
6.6.5 Fosun Pharma Recent Developments/Updates
6.7 Huahai Pharmaceuticals
6.7.1 Huahai Pharmaceuticals Company Information
6.7.2 Huahai Pharmaceuticals Description and Business Overview
6.7.3 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio
6.7.5 Huahai Pharmaceuticals Recent Developments/Updates
6.8 UCB Pharma
6.8.1 UCB Pharma Company Information
6.8.2 UCB Pharma Description and Business Overview
6.8.3 UCB Pharma Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 UCB Pharma Mesalazine Enteric Coated Tablets Product Portfolio
6.8.5 UCB Pharma Recent Developments/Updates
6.9 CR Sanjiu
6.9.1 CR Sanjiu Company Information
6.9.2 CR Sanjiu Description and Business Overview
6.9.3 CR Sanjiu Mesalazine Enteric Coated Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CR Sanjiu Mesalazine Enteric Coated Tablets Product Portfolio
6.9.5 CR Sanjiu Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mesalazine Enteric Coated Tablets Industry Chain Analysis
7.2 Mesalazine Enteric Coated Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mesalazine Enteric Coated Tablets Production Mode & Process Analysis
7.4 Mesalazine Enteric Coated Tablets Sales and Marketing
7.4.1 Mesalazine Enteric Coated Tablets Sales Channels
7.4.2 Mesalazine Enteric Coated Tablets Distributors
7.5 Mesalazine Enteric Coated Tablets Customer Analysis
8 Mesalazine Enteric Coated Tablets Market Dynamics
8.1 Mesalazine Enteric Coated Tablets Industry Trends
8.2 Mesalazine Enteric Coated Tablets Market Drivers
8.3 Mesalazine Enteric Coated Tablets Market Challenges
8.4 Mesalazine Enteric Coated Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Mesalazine Enteric Coated Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Mesalazine Enteric Coated Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Mesalazine Enteric Coated Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Mesalazine Enteric Coated Tablets Sales (Tons) of Key Manufacturers (2021–2026)
Table 5. Global Mesalazine Enteric Coated Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Mesalazine Enteric Coated Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Mesalazine Enteric Coated Tablets Average Price (US$/Ton) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Mesalazine Enteric Coated Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mesalazine Enteric Coated Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mesalazine Enteric Coated Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mesalazine Enteric Coated Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Mesalazine Enteric Coated Tablets Sales by Region (Tons), 2021–2026
Table 18. Global Mesalazine Enteric Coated Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Mesalazine Enteric Coated Tablets Sales by Region (Tons), 2027–2032
Table 20. Global Mesalazine Enteric Coated Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Mesalazine Enteric Coated Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Mesalazine Enteric Coated Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Mesalazine Enteric Coated Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2021–2026
Table 27. North America Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2027–2032
Table 28. North America Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Mesalazine Enteric Coated Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2021–2026
Table 32. Europe Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2027–2032
Table 33. Europe Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Mesalazine Enteric Coated Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Mesalazine Enteric Coated Tablets Sales by Region (Tons), 2021–2026
Table 37. Asia Pacific Mesalazine Enteric Coated Tablets Sales by Region (Tons), 2027–2032
Table 38. Asia Pacific Mesalazine Enteric Coated Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Mesalazine Enteric Coated Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Mesalazine Enteric Coated Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2021–2026
Table 42. Latin America Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2027–2032
Table 43. Latin America Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Mesalazine Enteric Coated Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2021–2026
Table 47. Middle East and Africa Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2027–2032
Table 48. Middle East and Africa Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Mesalazine Enteric Coated Tablets Sales (Tons) by Type (2021–2026)
Table 51. Global Mesalazine Enteric Coated Tablets Sales (Tons) by Type (2027–2032)
Table 52. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Type (2021–2026)
Table 59. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Type (2027–2032)
Table 60. Global Mesalazine Enteric Coated Tablets Sales (Tons) by Application (2021–2026)
Table 61. Global Mesalazine Enteric Coated Tablets Sales (Tons) by Application (2027–2032)
Table 62. Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Application (2021–2026)
Table 69. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Application (2027–2032)
Table 70. Dr. Falk Pharma GmbH Company Information
Table 71. Dr. Falk Pharma GmbH Description and Business Overview
Table 72. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 73. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product
Table 74. Dr. Falk Pharma GmbH Recent Developments/Updates
Table 75. Astellas Pharma Inc. Company Information
Table 76. Astellas Pharma Inc. Description and Business Overview
Table 77. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 78. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product
Table 79. Astellas Pharma Inc. Recent Developments/Updates
Table 80. AbbVie Inc. Company Information
Table 81. AbbVie Inc. Description and Business Overview
Table 82. AbbVie Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 83. AbbVie Inc. Mesalazine Enteric Coated Tablets Product
Table 84. AbbVie Inc. Recent Developments/Updates
Table 85. DSM Pharmaceuticals Company Information
Table 86. DSM Pharmaceuticals Description and Business Overview
Table 87. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 88. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product
Table 89. DSM Pharmaceuticals Recent Developments/Updates
Table 90. Sun Pharmaceutical Industries Ltd. Company Information
Table 91. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 92. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 93. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product
Table 94. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 95. Fosun Pharma Company Information
Table 96. Fosun Pharma Description and Business Overview
Table 97. Fosun Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 98. Fosun Pharma Mesalazine Enteric Coated Tablets Product
Table 99. Fosun Pharma Recent Developments/Updates
Table 100. Huahai Pharmaceuticals Company Information
Table 101. Huahai Pharmaceuticals Description and Business Overview
Table 102. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 103. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product
Table 104. Huahai Pharmaceuticals Recent Developments/Updates
Table 105. UCB Pharma Company Information
Table 106. UCB Pharma Description and Business Overview
Table 107. UCB Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 108. UCB Pharma Mesalazine Enteric Coated Tablets Product
Table 109. UCB Pharma Recent Developments/Updates
Table 110. CR Sanjiu Company Information
Table 111. CR Sanjiu Description and Business Overview
Table 112. CR Sanjiu Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 113. CR Sanjiu Mesalazine Enteric Coated Tablets Product
Table 114. CR Sanjiu Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Mesalazine Enteric Coated Tablets Distributors List
Table 118. Mesalazine Enteric Coated Tablets Customers List
Table 119. Mesalazine Enteric Coated Tablets Market Trends
Table 120. Mesalazine Enteric Coated Tablets Market Drivers
Table 121. Mesalazine Enteric Coated Tablets Market Challenges
Table 122. Mesalazine Enteric Coated Tablets Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mesalazine Enteric Coated Tablets
Figure 2. Global Mesalazine Enteric Coated Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Mesalazine Enteric Coated Tablets Market Share by Type: 2025 & 2032
Figure 4. 0.25g Product Picture
Figure 5. 0.5g Product Picture
Figure 6. 1g Product Picture
Figure 7. Global Mesalazine Enteric Coated Tablets Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Mesalazine Enteric Coated Tablets Market Share by Application: 2025 & 2032
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Mesalazine Enteric Coated Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Mesalazine Enteric Coated Tablets Market Size (US$ Million), 2021–2032
Figure 14. Global Mesalazine Enteric Coated Tablets Sales (Tons), 2021–2032
Figure 15. Global Mesalazine Enteric Coated Tablets Average Price (US$/Ton), 2021–2032
Figure 16. Mesalazine Enteric Coated Tablets Report Years Considered
Figure 17. Mesalazine Enteric Coated Tablets Sales Share by Manufacturers in 2025
Figure 18. Global Mesalazine Enteric Coated Tablets Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Mesalazine Enteric Coated Tablets Players: Market Share by Revenue in Mesalazine Enteric Coated Tablets in 2025
Figure 20. Mesalazine Enteric Coated Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Mesalazine Enteric Coated Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021–2032)
Figure 23. North America Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021–2032)
Figure 24. United States Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021–2032)
Figure 27. Europe Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021–2032)
Figure 28. Germany Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Mesalazine Enteric Coated Tablets Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2021–2032)
Figure 35. China Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021–2032)
Figure 43. Latin America Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Mesalazine Enteric Coated Tablets by Type (2021–2032)
Figure 54. Global Revenue Market Share of Mesalazine Enteric Coated Tablets by Type (2021–2032)
Figure 55. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Type (2021–2032)
Figure 56. Global Sales Market Share of Mesalazine Enteric Coated Tablets by Application (2021–2032)
Figure 57. Global Revenue Market Share of Mesalazine Enteric Coated Tablets by Application (2021–2032)
Figure 58. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Application (2021–2032)
Figure 59. Mesalazine Enteric Coated Tablets Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Mesalazine Enteric Coated Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Mesalazine Enteric Coated Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Mesalazine Enteric Coated Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Mesalazine Enteric Coated Tablets Sales (Tons) of Key Manufacturers (2021–2026)
Table 5. Global Mesalazine Enteric Coated Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Mesalazine Enteric Coated Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Mesalazine Enteric Coated Tablets Average Price (US$/Ton) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Mesalazine Enteric Coated Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mesalazine Enteric Coated Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mesalazine Enteric Coated Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mesalazine Enteric Coated Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Mesalazine Enteric Coated Tablets Sales by Region (Tons), 2021–2026
Table 18. Global Mesalazine Enteric Coated Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Mesalazine Enteric Coated Tablets Sales by Region (Tons), 2027–2032
Table 20. Global Mesalazine Enteric Coated Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Mesalazine Enteric Coated Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Mesalazine Enteric Coated Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Mesalazine Enteric Coated Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2021–2026
Table 27. North America Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2027–2032
Table 28. North America Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Mesalazine Enteric Coated Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2021–2026
Table 32. Europe Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2027–2032
Table 33. Europe Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Mesalazine Enteric Coated Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Mesalazine Enteric Coated Tablets Sales by Region (Tons), 2021–2026
Table 37. Asia Pacific Mesalazine Enteric Coated Tablets Sales by Region (Tons), 2027–2032
Table 38. Asia Pacific Mesalazine Enteric Coated Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Mesalazine Enteric Coated Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Mesalazine Enteric Coated Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2021–2026
Table 42. Latin America Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2027–2032
Table 43. Latin America Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Mesalazine Enteric Coated Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2021–2026
Table 47. Middle East and Africa Mesalazine Enteric Coated Tablets Sales by Country (Tons), 2027–2032
Table 48. Middle East and Africa Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Mesalazine Enteric Coated Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Mesalazine Enteric Coated Tablets Sales (Tons) by Type (2021–2026)
Table 51. Global Mesalazine Enteric Coated Tablets Sales (Tons) by Type (2027–2032)
Table 52. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Type (2021–2026)
Table 59. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Type (2027–2032)
Table 60. Global Mesalazine Enteric Coated Tablets Sales (Tons) by Application (2021–2026)
Table 61. Global Mesalazine Enteric Coated Tablets Sales (Tons) by Application (2027–2032)
Table 62. Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Application (2021–2026)
Table 69. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Application (2027–2032)
Table 70. Dr. Falk Pharma GmbH Company Information
Table 71. Dr. Falk Pharma GmbH Description and Business Overview
Table 72. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 73. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product
Table 74. Dr. Falk Pharma GmbH Recent Developments/Updates
Table 75. Astellas Pharma Inc. Company Information
Table 76. Astellas Pharma Inc. Description and Business Overview
Table 77. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 78. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product
Table 79. Astellas Pharma Inc. Recent Developments/Updates
Table 80. AbbVie Inc. Company Information
Table 81. AbbVie Inc. Description and Business Overview
Table 82. AbbVie Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 83. AbbVie Inc. Mesalazine Enteric Coated Tablets Product
Table 84. AbbVie Inc. Recent Developments/Updates
Table 85. DSM Pharmaceuticals Company Information
Table 86. DSM Pharmaceuticals Description and Business Overview
Table 87. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 88. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product
Table 89. DSM Pharmaceuticals Recent Developments/Updates
Table 90. Sun Pharmaceutical Industries Ltd. Company Information
Table 91. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 92. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 93. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product
Table 94. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 95. Fosun Pharma Company Information
Table 96. Fosun Pharma Description and Business Overview
Table 97. Fosun Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 98. Fosun Pharma Mesalazine Enteric Coated Tablets Product
Table 99. Fosun Pharma Recent Developments/Updates
Table 100. Huahai Pharmaceuticals Company Information
Table 101. Huahai Pharmaceuticals Description and Business Overview
Table 102. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 103. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product
Table 104. Huahai Pharmaceuticals Recent Developments/Updates
Table 105. UCB Pharma Company Information
Table 106. UCB Pharma Description and Business Overview
Table 107. UCB Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 108. UCB Pharma Mesalazine Enteric Coated Tablets Product
Table 109. UCB Pharma Recent Developments/Updates
Table 110. CR Sanjiu Company Information
Table 111. CR Sanjiu Description and Business Overview
Table 112. CR Sanjiu Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 113. CR Sanjiu Mesalazine Enteric Coated Tablets Product
Table 114. CR Sanjiu Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Mesalazine Enteric Coated Tablets Distributors List
Table 118. Mesalazine Enteric Coated Tablets Customers List
Table 119. Mesalazine Enteric Coated Tablets Market Trends
Table 120. Mesalazine Enteric Coated Tablets Market Drivers
Table 121. Mesalazine Enteric Coated Tablets Market Challenges
Table 122. Mesalazine Enteric Coated Tablets Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mesalazine Enteric Coated Tablets
Figure 2. Global Mesalazine Enteric Coated Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Mesalazine Enteric Coated Tablets Market Share by Type: 2025 & 2032
Figure 4. 0.25g Product Picture
Figure 5. 0.5g Product Picture
Figure 6. 1g Product Picture
Figure 7. Global Mesalazine Enteric Coated Tablets Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Mesalazine Enteric Coated Tablets Market Share by Application: 2025 & 2032
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Mesalazine Enteric Coated Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Mesalazine Enteric Coated Tablets Market Size (US$ Million), 2021–2032
Figure 14. Global Mesalazine Enteric Coated Tablets Sales (Tons), 2021–2032
Figure 15. Global Mesalazine Enteric Coated Tablets Average Price (US$/Ton), 2021–2032
Figure 16. Mesalazine Enteric Coated Tablets Report Years Considered
Figure 17. Mesalazine Enteric Coated Tablets Sales Share by Manufacturers in 2025
Figure 18. Global Mesalazine Enteric Coated Tablets Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Mesalazine Enteric Coated Tablets Players: Market Share by Revenue in Mesalazine Enteric Coated Tablets in 2025
Figure 20. Mesalazine Enteric Coated Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Mesalazine Enteric Coated Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021–2032)
Figure 23. North America Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021–2032)
Figure 24. United States Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021–2032)
Figure 27. Europe Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021–2032)
Figure 28. Germany Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Mesalazine Enteric Coated Tablets Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2021–2032)
Figure 35. China Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021–2032)
Figure 43. Latin America Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Mesalazine Enteric Coated Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Mesalazine Enteric Coated Tablets by Type (2021–2032)
Figure 54. Global Revenue Market Share of Mesalazine Enteric Coated Tablets by Type (2021–2032)
Figure 55. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Type (2021–2032)
Figure 56. Global Sales Market Share of Mesalazine Enteric Coated Tablets by Application (2021–2032)
Figure 57. Global Revenue Market Share of Mesalazine Enteric Coated Tablets by Application (2021–2032)
Figure 58. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Application (2021–2032)
Figure 59. Mesalazine Enteric Coated Tablets Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232